Veracyte to Present at Upcoming Investor Conferences
- 2019 Wells Fargo Healthcare Conference, Boston
Presentation on Thursday, September 5, 2019, at 9:10 a.m. ET
- 3rd Annual Janney Healthcare Conference, New York
Presentation on Monday, September 9, 2019, at 11:50 a.m. ET
- Morgan Stanley 17th Annual Global Healthcare Conference, New York
Fireside Chat on Tuesday, September 10, 2019, at 3:30 p.m. ET
Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. Replays of the webcasts will be available for 90 days following the conclusion of each live presentation broadcast.
Veracyte (Nasdaq: VCYT) is a leading genomic diagnostics company that improves patient care by providing trustworthy and actionable answers to challenging clinical questions. The company's products uniquely combine advanced genomic technology, clinical science and machine learning to provide answers that give patients and physicians a clear path forward, informing both diagnosis and treatment decisions without the need for costly, risky surgeries that are often unnecessary. Since its founding in 2008, Veracyte has commercialized seven genomic tests and is transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).
Veracyte, Afirma, Percepta, Envisia and the Veracyte logo are trademarks of Veracyte, Inc.
Source: Veracyte, Inc.